NASDAQ: ERNA
Ernexa Therapeutics Inc Earnings Dates, Reports, Calls

Ernexa Therapeutics earnings were -$12.3M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest ERNA earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$4.0M, down 27% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, ERNA reported annual earnings of -$14.1M, with -68.4% growth. The next ERNA earnings date is Nov 6, 2026.

ERNA earnings history

Current Revenue
$0.0
Current Earnings
-$12.3M
Current Profit Margin
0%

ERNA Return on Equity

Current Company
-306.3%
Current Industry
-13.6%
Current Market
31%
ERNA's Return on Equity (-306.3%)... subscribe to Premium to read more.
High Return on Equity Performance

ERNA Return on Assets

Current Company
-170.1%
Current Industry
-10.2%
ERNA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when ERNA announces earnings.

ERNA Return on Capital Employed

Current Company
-362.58%
Current Industry
-6.7%
ERNA's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ERNA vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ERNA-$12.00M-$12.27MN/A-$14.10
CURX-$10.34M-$10.47MN/A-$7.80
XTLB-$6.96M-$6.97MN/A-$3.20
INM-$11.84M-$12.99MN/A-$3.12
AIM-$12.25M-$14.27MN/A-$3.13

ERNA earnings dates

Next earnings date
Nov 6, 2026

Ernexa Therapeutics Earnings Reports & History FAQ

What were Ernexa Therapeutics's earnings last quarter?

On ERNA's earnings call on Aug 12, 2026, Ernexa Therapeutics (NASDAQ: ERNA) reported Q2 2026 earnings per share (EPS) of -$3.40, up 77.62% year over year. Total ERNA earnings for the quarter were -$4.02 million. In the same quarter last year, Ernexa Therapeutics's earnings per share (EPS) was -$15.19.

If you're new to stock investing, here's how to buy Ernexa Therapeutics stock.

When does Ernexa Therapeutics report earnings?

The next ERNA earnings call is Nov 6, 2026. Add ERNA to your watchlist to be reminded of Ernexa Therapeutics's next earnings date.

Is Ernexa Therapeutics profitable or losing money?

As of the last Ernexa Therapeutics earnings report, Ernexa Therapeutics is currently losing money. Ernexa Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$12.26 million, a 71.95% decrease year over year.

What was ERNA's earnings growth in the past year?

As of Ernexa Therapeutics's earnings date in Aug 12, 2026, Ernexa Therapeutics's earnings has grown year over year. ERNA earnings in the past year totalled -$12.27 million.

What are Ernexa Therapeutics's earnings expectations?

The current EPS estimate for Ernexa Therapeutics's earnings report in Nov 6, 2026 is -$3.84.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.